New study published in Lancet Infectious Diseases suggests that Bharat Biotech COVID19 vaccine, COVAXIN induces higher neutralising antibody response in children aged 2-18 years. The company had conducted an age de-escalation study to assess the safety, reactogenicity, and immunogenicity of an inactivated COVID-19 vaccine, COVAXIN.
Pharma News
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.











